No Data
10-Q/A: Quarterly report (Amendment)
Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements
Express News | Trading Halt: Halted at 7:55:00 A.m. ET - Trading Halt: Halt News Pending
Express News | PowerUp Acquisition: Aspire's Stockholders to Get Shares of Combined Co's Common Stock Equal to $316.8 Mln Less
Express News | PowerUp Acquisition Corp: On Aug 26 Entered Into Merger Deal With Aspire Biopharma
10-Q: Q2 2024 Earnings Report
No Data
No Data
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}